Israeli company claims oral COVID-19 vaccine on its way

DM

An oral vaccine could potentially allow for people to self vaccinate at home. An Israeli-American pharmaceutical company is preparing to launch a Phase I clinical trial for what could become the world’s first oral COVID-19 vaccine. Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company based on technology developed by Hadassah-University Medical Center, announced over the weekend a joint venture with India-based Premas Biotech to develop a novel oral vaccine. Together they formed the company Oravax Medical Inc. The vaccine is based on Oramed’s “POD” oral delivery technology and Premas’s vaccine technology.

Notifications - Subscriptions
Notify of
3 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

3
0
Would love your thoughts, please comment.x
()
x